10.28
2.07 (25.21%)
| Penutupan Terdahulu | 8.21 |
| Buka | 9.41 |
| Jumlah Dagangan | 5,616,094 |
| Purata Dagangan (3B) | 575,300 |
| Modal Pasaran | 292,189,120 |
| Harga / Pendapatan (P/E Ke hadapan) | 2.48 |
| Harga / Jualan (P/S) | 12.29 |
| Harga / Buku (P/B) | 1.36 |
| Julat 52 Minggu |
| Margin Keuntungan | -47.47% |
| Margin Operasi (TTM) | -57.27% |
| EPS Cair (TTM) | -2.52 |
| Pertumbuhan Hasil Suku Tahunan (YOY) | -22.70% |
| Jumlah Hutang/Ekuiti (D/E MRQ) | 18.25% |
| Nisbah Semasa (MRQ) | 5.64 |
| Aliran Tunai Operasi (OCF TTM) | -89.33 M |
| Aliran Tunai Bebas Leveraj (LFCF TTM) | -53.72 M |
| Pulangan Atas Aset (ROA TTM) | -13.67% |
| Pulangan Atas Ekuiti (ROE TTM) | -27.40% |
Arah Aliran Pasaran
| Jangka Pendek | Jangka Sederhana | ||
| Industri | Biotechnology (US) | Bercampur | Menaik |
| Biotechnology (Global) | Bercampur | Menaik | |
| Stok | Arcturus Therapeutics Holdings | Bercampur | Menurun |
AISkor Stockmoo
| Konsensus Penganalisis | NA |
| Aktiviti Orang Dalam | NA |
| Volatiliti Harga | -2.0 |
| Purata Bergerak Teknikal | 0.0 |
| Osilator Teknikal | 2.0 |
| Purata | 0.00 |
|
Arcturus Therapeutics Holdings Inc is an RNA medicines company focused on the development of infectious disease vaccines and opportunities within liver and respiratory rare diseases. It operates in one business segment, which includes all activities related to the discovery, development, and commercialization of messenger RNA medicines. The company's pipeline includes LUNAR-OTC and LUNAR-CF. Its Vaccine candidates include LUNAR-FLU, KOSTAIVE XBB.1.5, KOSTAIVE, and Others. |
|
| Sektor | Healthcare |
| Industri | Biotechnology |
| Gaya Pelaburan | Small Value |
| % Dimiliki oleh Orang Dalam | 7.89% |
| % Dimiliki oleh Institusi | 93.11% |
Tiada data dalam julat masa ini.
Tiada data dalam julat masa ini.
Tahap sokongan, rintangan dan garis aliran yang dibentangkan telah dihasilkan oleh model kecerdasan buatan (AI) dan harus ditafsirkan dengan berhati-hati.
Portfolio
| Keuntungan Nyata | - |
| Keuntungan Tidak Nyata | - |
| Dividen Diterima 2026 | - |
| Jumlah Untung | - |
| Pulangan Purata | - |
| Kuantiti (Beli) | - |
| Purata Harga (Beli) | - |
| Kuantiti (Jual) | - |
| Purata Harga (Jual) | - |